Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/01/2000CN1058004C Heterocyclo-benzoylguanidin
11/01/2000CN1058001C 4-Mercaptobenzoylguanidine derivatives
11/01/2000CN1057999C 4-Aminobenzoylguanidine derivatives
11/01/2000CN1057937C Use of lysozyme dimer and preparations containing same
11/01/2000CN1057926C Medicinal composition for curing gastrointestinal disease
11/01/2000CN1057917C Medicine for treatment of alopecia and making method thereof
11/01/2000CN1057908C Use of hyaluronic acid and forms to prevent arterial restenosis
11/01/2000CN1057907C Anti-cadmium medicines and their synthesis and medical application
10/2000
10/31/2000US6141589 Switch control for external pacing system
10/31/2000US6140532 O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same
10/31/2000US6140518 For use in the prevention or treatment of osteoporosis and related bone disorders.
10/31/2000US6140512 Process for the production of lipoic acid
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140492 Antisense transcript expressed in B lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
10/31/2000US6140491 Enzymatic nucleic acid which cleaves ribonucleic acids; has hammerhead motif and has at least one sugar-sugar backbone linkage which is different from a phosphodiester linkage; more stable than ribozymes; antisense agents; viricides
10/31/2000US6140481 Process for producing desulfated polysaccharide, and desulfated heparin
10/31/2000US6140374 Propofol composition
10/31/2000US6140373 Propofol composition
10/31/2000US6140372 Acyl derivatives of melatonin and of melatoninergic analogues and their use as medicinal products
10/31/2000US6140371 Therapeutic uses of known ester and amide compounds
10/31/2000US6140367 Immunosuppressive activity in addition to its antiviral activity; inhibition of phytohemagglutinin stimulated lymphocyte proliferation; aids, respiratory system and gastrointestinal disorders; vision defects
10/31/2000US6140366 Anticonvulsant therapy for central nervous system disorders, e.g., epilepsy, huntington's chorea, cerebral ischemia, parkinson's disease, tardive dyskinesia, antispasmodic and psychotic disorders; antidepressant, anxiolytic agents
10/31/2000US6140365 Preparation of microorganisms comprising omega-3-fatty acid for use as a prophylactic or therapeutic agent against parasitic diseases of animals
10/31/2000US6140364 Arachidonic acid metabolite, 16-HETE
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
10/31/2000US6140362 Method for inhibiting the growth of mammalian cells
10/31/2000US6140361 For inhibiting binding of human immunodeficiency virus rev protein to rev responsive elements (rre)
10/31/2000US6140359 Injectable composition
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/31/2000US6140356 Opthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositions
10/31/2000US6140355 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections
10/31/2000US6140354 N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
10/31/2000US6140353 Used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140350 Applying neonicotinoid compound for controlling ectoparasites through blood of a host animal
10/31/2000US6140348 Administering mast cell degranulation inhibitor ketotifen in an amount effective to prevent adverse myocardial remodeling secondary to sustained blood volume overload for treating and/or preventing heart failure
10/31/2000US6140346 For ameliorating symptoms of neoplastic diseases; anticarcenogenic agent
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140343 Cholesteryl ester transfer protein inhibitors which are used to elevate highdensity lipoprotein-cholesterol and to lower low density lipoprotein-cholesterol and triglycerides; for treating atherosclerosis, peripheral vascular disease, obesity
10/31/2000US6140342 Cholesteryl ester transfer protein inhibitor; used to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as ldl-cholesterol and triglycerides
10/31/2000US6140341 For treating pain
10/31/2000US6140340 Derivatives of 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydro isoquinoline, their process and their use as fungicides
10/31/2000US6140339 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
10/31/2000US6140337 Methods for the treatment of mental disorders
10/31/2000US6140336 Spiro[2H-1-benzopyran-2,4'-piperidine]-4(3H)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them
10/31/2000US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
10/31/2000US6140334 For treating high blood pressure, benign prostate hyperplasia
10/31/2000US6140332 Pyrrolopyrimidines and processes for the preparation thereof
10/31/2000US6140331 For treating anxiety disorders, depression, psychosis, impulse control disorders, alcohol abuse, ischaemic diseases, cardiovascular disorders, side effects induced by conventional antipsychotic agents and senile dementia
10/31/2000US6140329 For treating a male animal for erectile dysfunction
10/31/2000US6140328 Heterocyclic cytotoxic agents
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6140324 Use of a tachykinin antagonist and a muscarinic antagonist and/or an antihistamine to treat motion sickness
10/31/2000US6140323 Dosing method of administering medicaments via inhalation administration or skin administration
10/31/2000US6140321 Polymorphs of donepezil hydrochloride and process for production
10/31/2000US6140320 For treating hiv(human immunodeficiency virus) infections
10/31/2000US6140319 Administering an vasopeptidase inhibitor for treating and/or relieving the symptoms of angina pectoris
10/31/2000US6140317 Pyrrolopyrimidines and processes for their preparation
10/31/2000US6140315 Administering to a human or an animal an amount of goserelin acetate sufficient to decrease atherosclerosis and its complications
10/31/2000US6140313 Butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
10/31/2000US6140312 Nontoxic, for treating skin diseases
10/31/2000US6140311 Therapy by intrathecal administration of antitumor agent FUDR
10/31/2000US6140309 Inhibiting the vasoactive effects of beta-amyloid peptides by exposing vessel to a modifier of superoxide formation prior to exposure of the vessel to a amyloid peptide
10/31/2000US6140308 Colon or ileum-specific glucocorticosteroid derivatives
10/31/2000US6140307 Pharmaceutical composition
10/31/2000US6140306 Concurrently administering to a patient a (bpi)bactericidal/permeability-increasing protein and a tetracyline antibiotic in the treatment of a patient infected with escherichia gram-negative bacterial species
10/31/2000US6140304 Administering to the patient a thearapeutical dosage of solid food product containing protein source, carbohydrate source, a fat source containing activated omega 3 and omega 6 essential fatty acids to control insulin and glucagon level
10/31/2000US6140125 Antisense inhibition of bcl-6 expression
10/31/2000US6140124 Nucleotide sequences which target untranslated regions, translation start site and translation termination position; for diagnosis and treatment of tumors, inflammation and arthritis; antitumor agents; inflammatory agents
10/31/2000US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
10/31/2000US6140099 Administering to human a matrix metalloproteinase-9 inhibitor in an amount effective to delay the onset of fetal membrane rupture, wherein said matrix metalloproteinase-9 inhibitor is a hydroxamic acid-based compound
10/31/2000US6140063 In vitro screening assay for identification of compounds that inhibit cytopathicity of viral infection
10/31/2000US6140061 Response regulator
10/31/2000US6140052 Diagnosing and treating cancers by determining the presence or absence in a cell of wild-type adenomatous polyposis coli (apc) or a wild-type downstream protein in the apc transcription regulatory pathway
10/31/2000US6140043 Pharmaceutical composition comprising a protein, peptide or a functionally equivalent molecule
10/31/2000US6139877 Spheroids containing tiagabine, preparation process and pharmaceutical compositions
10/31/2000US6139873 Contraceptives; hormone replacement therapy
10/31/2000US6139866 Tape formulation for percutaneous administration containing fentanyi
10/31/2000US6139865 Taste-masked microcapsule compositions and methods of manufacture
10/31/2000US6139864 A food or medicine containing a zinc compound and an antimicrobially effective amount of a sugar alcohol mixture without complexing with zinc compound; treatment and prevention of viral cold
10/31/2000US6139863 Suppositories
10/31/2000US6139861 Applying directly to the mucous membrane of the mouth in the maxillary third molar apical area with at least one anti-inflammatory medicine selected from non-steroid antiinflammatory drugs and glucocorticoid steroids
10/31/2000US6139860 Method of stimulating cilia
10/31/2000US6139856 Composition useful for providing one-step surgical preparation and drape
10/31/2000US6139850 A strontium compound as antiallergens to provide fast-acting, efficient and safe topical skin anti-irritant effects
10/31/2000US6139841 Activating immune response in an individual for treatment or prevention of cancer
10/31/2000US6139821 Materials and methods utilizing a temporary visual indicator
10/31/2000US6138683 Smokeless tobacco products containing antioxidants
10/31/2000US6138680 Method for destroying retinal pigment epithelial cells
10/31/2000CA2224565C Agent for combating parasites in farmed fish
10/31/2000CA2204180C Melt-extruded orally administrable therapeutically active formulations
10/31/2000CA2189658C Controlled-release dosage forms of azithromycin
10/31/2000CA2182004C Film coated tablet of paracetamol and domperidone
10/31/2000CA2179305C Novel and improved aminoglycoside formulation for aerosolization
10/31/2000CA2175451C Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
10/31/2000CA2152621C Pharmaceutical compositions comprising contignasterol compounds
1 ... 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 6236 6237 6238 6239 ... 7860